公司产品2024年批签发情况如下表:
The company's product 2024 annual batch issuance situation is as follows:
序号 Serial No. |
产品名称 Product Name |
批次 Batch |
1 |
无细胞百白破b型流感嗜血杆菌联合疫苗 Diphtheria, Tetanus, Acellular Pertussis and Haemophilus influenzae type b combined vaccine |
0批 0 batch |
2 |
23价肺炎球菌多糖疫苗 23-valent pneumococcal polysaccharide vaccine |
4 批 4 batch |
3 |
13价肺炎球菌多糖结合疫苗(破伤风类毒素/白喉类毒素) 13- valent pneumococcal polysaccharide conjugate vaccine(TT/DT) |
5 批 5 batch |
4 |
吸附无细胞百白破联合疫苗 Diphtheria, Tetanus and Acellular Pertussis combined vaccine,Adsorbed |
0 批 0 batch |
5 |
冻干b型流感嗜血杆菌结合疫苗
Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
|
2 批
2 batch
|
6 |
冻干人用狂犬病疫苗(人二倍体细胞) Rabies Vaccine (Human Diploid Cell) for Human Use, Freeze-dried |
0 批
0 batch
|
批签发公示:
Batch release announcement: